Physician profile
John Hayes
NPI 1801868021
$2,186.02
in general payments reported to CMS, 2019-2025
29 companies · $425 in 2025
The $425 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $227 · 2020: $285 · 2021: $314 · 2022: $369 · 2023: $415 · 2024: $152 · 2025: $425.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $992.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $991.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $691.32 | 2019-2025 | Echelon; Endopath, Echelon Endopath, Stratafix |
| Endologix LLC | $438.33 | 2019-2025 | Afx2 Bifurcated Endograft System, Ovation Ix Iliac Stent Graft |
| Organogenesis INC. | $195.04 | 2022-2023 | Puraply |
| Becton, Dickinson and Company | $96.34 | 2022 | |
| Davol INC. | $77.38 | 2022-2023 | Progel Applicator Spray Tips |
| Innocoll Pharmaceuticals Limited | $58.86 | 2021-2022 | |
| Vertex Pharmaceuticals Incorporated | $54.54 | 2025 | |
| Smith+Nephew, INC. | $52.78 | 2019 | |
| Medtronic, INC. | $51.79 | 2021-2022 | |
| Heron Therapeutics, INC. | $49.38 | 2025 | Zynrelef |
| Silk Road Medical, INC. | $47.97 | 2021-2022 | |
| Kci USA, INC. | $41.68 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $35.56 | 2019 | |
| Merz Pharmaceuticals, LLC | $29.02 | 2024 | Xeomin |
| Takeda Pharmaceuticals U.S.A., INC. | $28.40 | 2021-2023 | Gattex |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acera Surgical, INC. | $25.82 | 2019-2020 | |
| Innovation Technologies INC | $20.52 | 2025 | Irrisept |
| Solventum Corporation | $20.24 | 2024 | Prevena, V.A.C. Veraflo Cleanse Choice |
| W. L. Gore & Associates, INC. | $18.73 | 2022 | |
| Acell, INC. | $18.45 | 2020 | |
| Allergan, INC. | $18.36 | 2019 | |
| Medline Industries LP | $18.08 | 2020 | |
| Baudax Bio INC. | $17.36 | 2020 | |
| Medtronic Vascular, INC. | $17.23 | 2020 | |
| Somavac Medical Solutions, INC. | $16.50 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $13.18 | 2023 | Seglentis |
| Kerecis Limited | $12.57 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Bolder Surgical, LLC | $11.97 | 2022 | |
| Bolder Surgical LLC | $8.62 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Hayes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.